Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANNA-TICS: Nabiximols in Chronic Tic Disorders
NCT03087201Phase 3Completed
- Sponsor
- Hannover Medical School
- Start
- Apr 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabis extract in Tourette syndrome (TS), chronic tic disorder, sponsored by Hannover Medical School. Started Apr 2018; status: completed.
02
Drugs
cannabis extract
03
Conditions
Tourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on NCT03087201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087201.